Mereo BioPharma Group plc
MREO
$0.24
-$0.01-4.75%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -7.01M | -6.72M | -7.35M | -7.02M | -14.62M |
| Total Depreciation and Amortization | 299.00K | 305.00K | 592.00K | -11.00K | 298.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.66M | -59.00K | 1.32M | -674.00K | 7.51M |
| Change in Net Operating Assets | -997.00K | 2.16M | -2.25M | 400.00K | -843.00K |
| Cash from Operations | -6.04M | -4.31M | -7.68M | -7.31M | -7.65M |
| Capital Expenditure | -- | -- | 0.00 | 0.00 | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | -300.00K | 0.00 | 300.00K | 0.00 |
| Cash from Investing | 0.00 | -300.00K | 0.00 | 300.00K | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 39.00K | 0.00 | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 0.00 | 0.00 | -134.00K |
| Cash from Financing | -- | -- | 39.00K | 0.00 | -134.00K |
| Foreign Exchange rate Adjustments | -62.00K | -157.00K | -63.00K | -418.00K | 1.43M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -6.11M | -4.77M | -7.71M | -7.43M | -6.36M |